Oxford-based Owen Mumford launches new self-testing device to provide rapid, accurate and easy at-home HIV testing
Lockdown presents once in a lifetime chance to combat fatal disease
A leading medical device company has launched a new HIV self-testing kit that could help thousands of undiagnosed people to access fast and potentially life-saving treatment at an earlier stage.
And with lockdown reducing the number of casual sexual encounters, which in turn is reducing the number of HIV transmissions, never has there been a better time to combat the disease and protect a generation’s future health says Oxford-based business Owen Mumford.
Owen Mumford has launched Simplitude ByMe™ as a reliable, simple to use and accurate test which it hopes will make HIV testing more accessible.
Shaun Watson, Nurse, Community HIV Specialist and Chair of the National HIV Nurses Association welcomes the launch for its ease-of-use: “It’s a great new HIV self-test, and probably the simplest to use that I’ve tried. We need to support people in feeling comfortable and able to test themselves for HIV and this launch is an excellent step towards that goal.”
Leanne Adam, Marketing Manager for Owen Mumford, says that while transmission rates are falling, complacency is the biggest threat: “There are still too many people who remain undiagnosed,” she says.
“The reasons behind this may be lack of awareness of the importance of regular testing, or because of an ill-conceived stigma around testing and HIV. We want to change this. Simplitude ByMe™ is a reliable rapid diagnostic test which can be bought online, is easy to operate and can be used by an individual at a time and a place that is convenient.”
The launch comes in the wake of news from the London-based sexual health clinic, Dean Street, that suggests HIV transmissions have plummeted in London as the Nation has stayed indoors. It believes this presents a once-in-a-generation opportunity in the fight against HIV; if everybody gets tested and knows their status, they can make the right health choices to look after themselves and others. People that test positive can start medication straight away, which in turn means they could prevent passing on the disease.
“At Owen Mumford, we want the availability of Simplitude ByMe™ to encourage more people to test themselves regularly so that those who test positive can access life-saving treatment at an early stage,” Leanne adds.
The latest figures from Public Health England estimate that in 2018 there were 7,500 people who were unaware that they were living with HIV. Of these, three in five were diagnosed early which means that they are able to take antiretroviral (ART) drugs which effectively control the virus and help prevent transmission, allowing people with HIV to enjoy healthy, long and productive lives.
Anyone having unprotected casual sex has a higher chance of contracting HIV, so regular testing is encouraged for anyone who may be at risk.
Simplitude ByMe™ self-test kit is available to discreetly purchase by visiting www.simplitudebyme.com
More in Health
Activate Business School launches new education programme for aspiring health leaders
Activate Business School is delighted to announce it is launching a new award to help develop and train health and care staff across Buckinghamshire Oxfordshire and Berkshire (BOB).
CEO FOCUS: Take Your Best Shot
A fascinating interview with Thomas Hal Robson-Kanu, international professional football player and founder of The Turmeric Co, one of the UK’s fastest growing health brands.
Blenheim to Host European Transplant and Dialysis Games
Blenheim is set to host three days of competition as part of the European Transplant and Dialysis Games which will arrive in the UK next week (23rd-25th August) for the first time ever.
From this author
Owen Mumford’s Near-Term and Net-Zero targets approved by the SBTi
Owen Mumford, a leader in the medical device industry and certified B Corp, has announced that the Science Based Targets initiative (SBTi) has approved its near-term science-based emissions reduction target. The medical device manufacturer has also committed to set long-term emissions reduction targets with the SBTi in line with reaching net-zero by 2045 – 5 years ahead of the UK’s net-zero target.
Owen Mumford acquires Empelvic
Owen Mumford Expands Pelvic Health Portfolio with Acquisition of Empelvic
Owen Mumford partners with Duopharma Biotech to distribute medical devices
Partnership with leading pharmaceutical company will supply diabetes and eye care devices in the Malaysia and Brunei markets